Cytokine Storm | NEJM
Review Article from The New England Journal of Medicine — Cytokine Storm
Related Articles
Thoracic Radiotherapy Improves the Survival in Patients With EGFR-Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial
PURPOSEThis multicenter, randomized, phase III clinical trial (Northern Radiation Oncology Group of China-002) focused on patients with oligo-organ metastatic non–small cell lung cancer (NSCLC) who…
Advancing Pelvic Sarcoma Reconstruction with 3D Printing
Lukas Nystrom, MD, Orthopaedic Oncology Surgeon and a Co-Director of the Sarcoma Program at Cleveland Clinic joins the Cancer Advances Podcast to talk about the…
The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trials
Acute toxicity following prostate radiotherapy was statistically significantly associated with late toxicity and with decrement in patient-reported QOL metrics. These data support efforts to evaluate…
In Wendy’s Memory: Support for the Shaffer Family, organized by Friends of the Shaffer Family
**In Loving Memory of Wendy Jo Shaffer: Support for Her Belov… Friends of the Shaffer Family needs your support for In Wendy’s Memory: Support for…
Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients
Annals of Surgical Oncology – Distant metastases are the strongest predictor of poor prognosis for patients with neuroendocrine tumors (NETs). Cytoreductive hepatectomy (CRH) can relieve…
National Science Foundation suspends salary payments, leaving researchers unable to pay their bills
An NSF online payment system remained down after the federal funding freeze was lifted, leaving early-career scientists scrambling to pay bills
Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas
PURPOSEOutcomes for patients with advanced sarcomas are poor and there is a high unmet need to develop novel therapies. The purpose of this phase I…
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer
PURPOSETo assess trial-level surrogacy value for overall survival (OS) of the pathologic complete response (pCR) and invasive disease-free survival (iDFS) in randomized clinical trials (RCTs)…
What Clinicians Want to Know: Addressing Current Questions Related to Novel Treatment Approaches for Urothelial Bladder Cancer and Prostate Cancer — Thursday, February 13, 2025 — San Francisco | Research To Practice
Thursday, February 13, 2025, San Francisco, California, 7:00 PM – 9:00 PM Pacific Time (10:00 PM – 12:00 AM Eastern Time) Location San Francisco Marriott…
next level freedom
Getting home by dinner most nights WITHOUT bringing any work home Stabilizing staff turn-over in a mid-sized private practice without working 24/7 Six-figure raises while…
